MPO and coronary artery disorder: Increased oxTrp72-apoA1 levels were correlated with an increased coronary artery disease risk and cardiovascular risk, even after adjusting for traditional CVD risk factors, i.e., apoA1, MPO, and high sensitivity C-reactive protein levels, and lipid lowering medication use [107].